Table 1.
Study | Study design | Modality | Population | Features type | Features selection | Model algorithm | Type of validation | Outcome |
---|---|---|---|---|---|---|---|---|
Du et al. (2020) |
Retrospective Single-center |
PET/CT |
77 Tuberculosis 79 Lung cancers |
Clinical Semantic Handcrafted radiomic |
LASSO | LR |
Leave one out Without external validation |
Diagnosis |
Sibille et al. (2020) |
Retrospective Single-center |
PET/CT |
302 lung cancer 327 lymphoma |
Deep radiomic | CNN | CNN |
Leave one out Without external validation |
Diagnosis |
Kang et al. (2019) |
Retrospective Single-center |
PET/CT |
157 malignant 111 benign patients |
Clinical Handcrafted radiomic |
LASSO | LR |
Bootstrapping validation Without external validation |
Diagnosis |
Han et al. (2020) |
Retrospective Single-center |
PET/CT |
867 adenocarcinomas 552 SCCs |
Handcrafted radiomic Deep radiomic |
Ten feature selection methods | 10 ML models and the VGG16 |
Leave one out Without external validation |
Diagnosis |
Kirienko et al. (2018) |
Retrospective Single-center |
PET/CT | 534 Lung lesions | Handcrafted radiomic | – | LDA |
Leave one out Without external validation |
Primary or metastatic lung lesions |
Shao et al. (2020) |
Retrospective Single-center |
PET/CT | 91 GGNs |
Semantic Handcrafted radiomic |
LASSO | LR |
Bootstrapping validation Without external validation |
Lepidic or acinar-papillary growth |
Zhang et al. (2020) |
Retrospective Single-center |
PET/CT | 248 NSCLCs |
Clinical Handcrafted radiomic |
LASSO | LR |
Leave one out Without external validation |
EGFR mutation |
Liu et al. (2020) |
Retrospective Single-center |
PET/CT | 148 Adenocarcinomas | Handcrafted radiomic | RF/LR | Xgboost |
Leave one out Without external validation |
EGFR mutation |
Mu et al. (2020) |
Retrospective Multi-center |
PET/CT | 681 NSCLCs | Deep radiomic | CNN | CNN |
Leave one out With external validation |
EGFR mutation Treatment response |
Yang et al. (2020) |
Retrospective Single-center |
PET/CT | 315 NSCLCs |
Clinical Handcrafted radiomic |
LASSO | LR |
Leave one out Without external validation |
Survival |
Mu et al. (2019) |
Retrospective/ prospective Single-center |
PET/CT | 194 Stage IIIB-IV NSCLCs |
Clinical Handcrafted radiomic |
LASSO | LR |
Leave one out With external validation |
Survival after immunotherapy |
Dissaux et al. (2020) |
Retrospective Multi-center |
PET/CT | 87 Early-stage NSCLCs |
Clinical Semantic Handcrafted radiomic |
Univariate/ Multivariate analysis |
Cox |
Leave one out With external validation |
Local Recurrence after radiotherapy |
SCC, squamous cell carcinoma; NSCLC, non-small cell lung cancer; GGN, ground-glass nodule; LASSO, least absolute shrinkage and selection operator; CNN, convolutional neural network; RF, random forest; LR, logistic regression; ML, machine learning; EGFR, epidermal growth factor receptor